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Cone–rod dystrophy 1 (cord1) is a recessive condition that occurs naturally in miniature longhaired dachshunds (MLHDs). We mapped the
cord1 locus to a region of canine chromosome CFA15 that is syntenic with a region of human chromosome 14 (HSA14q11.2) containing the
retinitis pigmentosa GTPase regulator-interacting protein 1 (RPGRIP1) gene. Mutations in RPGRIP1 have been shown to cause Leber
congenital amaurosis, a group of retinal dystrophies that represent the most common genetic causes of congenital visual impairment in infants
and children. Using the newly available canine genome sequence we sequenced RPGRIP1 in affected and carrier MLHDs and identified a 44-
nucleotide insertion in exon 2 that alters the reading frame and introduces a premature stop codon. All affected and carrier dogs within an
extended inbred pedigree were homozygous and heterozygous, respectively, for the mutation. We conclude the mutation is responsible for cord1
and demonstrate that this canine disease is a valuable model for exploring disease mechanisms and potential therapies for human Leber
congenital amaurosis.
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Inherited retinal degenerations encompass a diverse group of
disorders that cause severe visual impairment in humans and
other mammalian species. They are characterized by age of
onset and mode of inheritance and are among the most
genetically heterogeneous inherited disorders. Animal models
of retinal degenerative conditions, for which the genetic basis is
understood and which share clinical features with their human⁎ Corresponding author. Fax: +44 8700 50 24 61.
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doi:10.1016/j.ygeno.2006.05.004counterparts, serve as valuable tools with which to study the
pathophysiology of disease and the development of therapeutic
strategies to intervene in these conditions. A powerful example
of the value of such animal models is provided by the work of
Acland and colleagues, who successfully used gene therapy to
restore visual function in a canine Briard model of Leber
congenital amaurosis [1].
The dog has long been endorsed as an unparalleled model
for the study of human disease [2], a claim substantiated by
the increasing number of pathogenic mutations described for
naturally occurring canine diseases, including many models
of retinal degeneration (see for example the following and
references therein [3–15]). Models for autosomal-recessive,
autosomal-dominant, and X-linked retinitis pigmentosa (RP)
are provided by canine models with mutations in the α and β
subunits of cGMP phosphodiesterase (PDE6A and PDE6B)
294 C.S. Mellersh et al. / Genomics 88 (2006) 293–301[11–13], rhodopsin (RHO) [14], and the RP GTPase regu-
lator (RPGR) [15], respectively. Mutations in the canine
RPE65 [16] and CNGB3 [17] genes provide additional
models for human Leber congenital amaurosis (LCA) and
achromatopsia.
The canine inherited retinal diseases for which causal
mutations have been identified are almost exclusively rod–
cone dysplasias or degenerations, which are characterized by
progressive rod-led photoreceptor degeneration that is fol-
lowed by the secondary, progressive demise of the cone
photoreceptors. These canine conditions are collectively
known as progressive retinal atrophies (PRAs) and are
homologous to human RP. An exception is achromatopsia,
which is a condition characterized by day blindness caused by
lack of cone function.
In contrast to rod–cone dystrophies, such as RP, cone–rod
dystrophies (CRDs) are characterized by the relatively early
loss of the cone photoreceptors. To date, the only animal
models corresponding to human CRDs for which the gene
responsible is known are provided by transgenic mice with
mutations in the cone–rod homeobox (Crx) [18] and
peripherin (Rds) [19] genes; no large animal models of
cone–rod dystrophies have been described. Acland and
colleagues have described canine models for cone–rod
dystrophies (crd1 and crd2) that share clinical features with
human cone–rod dystrophies, but the causal mutations for
these conditions have yet to be identified [20].
A form of generalized PRA has previously been described in
the miniature long-haired dachshund (MLHD) [21]. The earliest
ophthalmoscopic signs appear at approximately 6 months of age
and the inheritance is consistent with that of an autosomal
recessive condition. Recently, Turney and colleagues [22]
further characterized this canine model of retinal degeneration
by carrying out extensive electrophysiological recordings, the
results of which were compared with the morphological, lectin-
binding, and immunohistochemical changes identified within
the retina. Their findings suggest that this PRA is in fact a cone–
rod dystrophy and not, as implied earlier, a primary rod
degeneration with suggested secondary cone loss. We have
termed this condition in MLHDs cord1.
In parallel to the electrophysiological studies described
above, we have mapped the cord1 locus to a region on canine
chromosome 15 showing synteny with human chromosome
14q11.2. This region contains the gene encoding the retinitis
pigmentosa GTPase regulator-interacting protein (RPGRIP1).
Mutations in RPGRIP1 have been shown to cause a form of
LCA, a group of autosomal retinal dystrophies that represent the
earliest and most severe form of all inherited retinal dystrophies
responsible for congenital blindness. Human patients with
RPGRIP1 mutations have a degeneration of both rod and cone
photoreceptors and experience a severe loss of central acuity
early in life. We have sequenced RPGRIP1 in MLHDs and have
identified a mutation associated with cord1. The discovery and
characterization of a canine model for LCA provides new
opportunities for studying the pathophysiology of cone–rod
dystrophies and the development of therapeutic strategies, such
as gene therapy, to intervene in these diseases.Results
Genetic linkage analysis
One hundred eight canine microsatellite markers were
genotyped on 3 affected and 3 obligate carrier dogs. Four
markers that were monomorphic in the affected dogs and
polymorphic in the carrier dogs were genotyped on an extended
inbred pedigree of 32 MLHDS segregating cord1, from which
DNA was available from 30 dogs. One marker, CPH4
(http://www.ensembl.org/Canis_familiaris/markerview?
marker=CPH4), was linked to the cord1 locus with a maximum
lod score of 5.32 at a recombination fraction of 0.00. CPH4
maps at 42.11Mb on CFA15 in the current whole genome
sequence assembly. All marker positions stated in megabases
(Mb) refer to positions identified in the current full Ensembl
gene build for Canis familiaris (CanFam 1.0: http://www.
ensembl.org/Canis_familiaris/) [23].
To identify the location of the cord1 locus more precisely,
additional microsatellites from CFA15 were genotyped on the
MLHD pedigree, using either markers derived by screening a
canine BAC library (AHT43n7, AHT61G2_2, and AHT
61G2_7) [24] or published markers. Multiple markers on
CFA15 displayed significant evidence of linkage to cord1
(Table 1).
Analysis of genotyping data revealed three different disease
chromosomes and a single unaffected chromosome segregating
in the pedigree (depicted in green, red, orange, and blue,
respectively; Fig. 1). A minimal haplotype that extended from
FH3833 (16.52 Mb) to Ren265J03 (30.67 Mb) and that was
shared by all disease chromosomes was identified. Haplotype
analysis revealed two individual dogs (523 and 1646) with
obligate recombinations between cord1 and FH3833, and
another dog (811) with an obligate recombination between
cord1 and Ren265M23, but none with recombinations between
cord1, Ren06C11, 61G2_E2, or 61G2_E7. This result indicates
that the order of loci on CFA15 in the proximity of cord1 is
FH3833–[cord1, Ren06C11, 61G2_E2, 61G2_E7]–
Ren265M23, which confirms the microsatellite order indicated
in CanFam 1.0 and reported elsewhere [25,26]. It is not possible
to determine the order between cord1, Ren06C11, 61G2_E2,
and 61G2_E7 as no recombinations have been observed
between these loci in the pedigree used in this study.
Ren06C11, 61G2_E2, and 61G2_E7, which are situated on
the same BAC clone (BAC61G2), are in fact located within
46 kb of one another, at 21,162,078–21,162,158, 21,169,857–
21,169,998, and 21,123,947–21,124,129 nucleotides, respec-
tively (CanFam 1.0). FH3833 and Ren265M23 have been
positioned at 16.52 and 30.67 Mb, respectively, on CFA15,
which narrows the critical region containing the cord1 locus to
14.15 Mb.
Establishing the human syntenic region
FH3833 maps to a region of CFA15 syntenic with human
chromosome 1, whereas Ren265J03 maps to a region syntenic
with human chromosome 12 (http://www.ensembl.org/
Table 1
Summary of markers in the cord1 region, showing position on CFA15, syntenic regions of human genome, and maximum two-point lod scores and recombination
fractions of markers typed on cord1 pedigree
Marker a Maximum lod score
(recombination frequency)
Type of marker UniSTS Position on
CFA15 (Mb) b
Human chromosome Position on
HSA (Mb)
BAC_376-I5 BAC 262442 11.64 1 52.60
EST29C3 EST 263331 12.48 1 51.50
FH4012 Micro 263986 13.90 1 50.00
AHTH257 Monomorphic Micro 262054 15.66 1 47.90
AHT43n7 4.27 (0.07) Micro c 1 47.90
█FH3833 3.64 (0.08) Micro 263930 16.52 1 46.80
█BAC_381-D2 BAC 262519 18.39 1 44.80
█BAC_382-O14 BAC 262676 18.99 1 44.20
█BAC_381-O17 BAC 262602 19.10 1 43.00
█EST8D7 EST 263428 19.98 1 43.00
█CFOR03E02 Gene 262858 20.38 15 18.10
█EST16C9 EST 263140 20.79 14 18.90
█REN06C11 7.43 (0.00) Micro 264197 21.16 14 19.50
█61G2_E2 7.43 (0.00) Micro d 14 19.50
█61G2_E7 7.43 (0.00) Micro d 14 19.50
█REN307J23 Monomorphic Micro 264663 24.68 12 77.90
█MYF5 Gene 264116 26.05 12 81.50
█REN247M23 Monomorphic Micro 264544 26.09 12 79.70
█REN122C19 Monomorphic Micro 264260 26.25 12 79.90
█FH3813 Micro 263924 28.90 12 83.10
█BAC_376-N11 BAC 262461 29.66 12 84.00
█REN265J03 5.54 (0.03) Micro 264590 30.67 12 85.70
FH2535 Micro 263590 31.16 12 85.10
FH3689 Micro 263898 32.16 12 86.90
EST20F2 EST 263222 32.35 12 87.10
FH2171 Micro 263523 33.03 12 87.90
EST13H11 EST 263102 33.56 12 88.50
STS122I11 SNP, STS 264881 35.60 12 90.97
FH2017 2.14 (0.07) Micro 263492 37.91 12 93.80
REN159B09 Micro 264358 38.05 12 94.00
REN303E22 Micro 264655 39.32 12 95.50
REN134K05 Micro 264296 39.69 12 95.90
RVC1 3.158 (0.08) Micro 264843 40.76 12 97.20
REN143N23 Micro 264312 41.19 12 97.70
CPH4 5.32 (0.00) Micro 262934 42.11 12 98.80
Abbreviations used: BAC, bacterial artificial chromosome; Micro, microsatellite; EST, expressed sequence tag; STS, sequence tagged site; SNP, single nucleotide
polymorphism.
a Markers indicated by black bar are within cord1critical region.
b Data from current full Ensembl gene build for Canis familiaris CanFam 1.0: http://www.ensembl.org/Canis_familiaris/.
c Not mapped in CanFam 1.0 but cloned on same BAC (BAC 43n7) as AHTH257.
d Not mapped in CanFam 1.0 but cloned on same BAC (BAC61G2) as Ren06C11.
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the cord1 locus is located close to the evolutionary breakpoint
between human chromosomes 1 and 12 on CFA15. To
establish on which side of the breakpoint cord1 was located,
we sequenced 96 subclones from BAC 61G2 (containing
microsatellites Ren06C11, R61G2_E2, and 61G2_E7) and
analyzed the results using BLASTn. Of the 96 subclone
sequences identified, 65 showed significant homology with
human sequences (scores of 52–868, supported by E values of
5e−4 to e−173), 51 (78%) of which had homology to chromo-
some 14q11. This result indicated that Ren06C11, 61G2_E2,
and 61G2_E7 reside on a region of CFA15 that is syntenic
with human chromosome 14q11. The presence of a chromo-
some segment on CFA15 that is syntenic with HSA14q has
been confirmed by other studies [25] (http://www.ensembl.
org/Canis_familiaris/).BLASTn analysis was undertaken for all the markers on
CFA15, in the region of cord1, for which sequence was
available in public databases. For markers whose sequences
were unavailable we compared the published forward and
reverse primer sequences with canine whole genome shotgun
(WGS) sequences in public databases. Sequences with
significant homology to both the forward and the reverse
primers for a given marker were assembled into contigs that
were then compared with the NCBI chromosome database
for homologous regions of the human genome. The markers
displaying significant homology to human sequences are
indicated in Table 1. The results indicate the extent of the
regions of CFA15 that are syntenic with human chromo-
somes 1, 14, and 12. It is notable that the order of markers
along CFA15, according to CanFam 1.0 (http://www.
ensembl.org), does not always correspond to the order of
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some, according to the NCBI 35 assembly of the human ge-
nome (http://www.ncbi.nlm.nih.gov/mapview/stats/BuildStats.
cgi?taxid=9606&build=35). The chromosomal order is pre-
served for those CFA15 markers we have analyzed that are
syntenic with HSA1 and HSA14, but differences exist in the
order of CFA15 markers that are syntenic with markers on
HSA12 (Table 1). These differences may reflect true
rearrangements of CFA15, with respect to the ancestral
chromosomes, that have resulted in differences in gene order
between dog and human chromosomes or, alternatively, may
be due to small-scale inaccuracies in the genome assemblies
of either CFA15 or HSA12.
Ren06C11, showing strong linkage with cord1, has been
positioned on the current whole genome sequence assembly at
21.16 Mb, in a region syntenic with human chromosome 14.
DNA flanking REN06C11 displays homology with HSA14 at
20.6 Mb.
Retinitis pigmentosa GTPase regulator-interacting protein 1
Consideration of the homologous region of HSA14 revealed
one strong candidate gene for the cord1 mutation: the retinitis
pigmentosa GTPase regulator-interacting protein 1 (RPGRIP1)
(located at 20.8 Mb on HSA14 (http://www.ensembl.org/
Homo_sapiens/geneview?gene=ENSG00000092200)). Muta-
tions in RPGRIP1 have been demonstrated to cause a form of
Leber congenital amaurosis [28,29], a group of autosomal
retinal dystrophies that represent the most common genetic
causes of congenital visual impairment in infants and children.
The sequence of canine RPGRIP1 cDNA has not been
determined so RPGRIP1 cDNA sequences from other species
available in public databases were aligned with the canine
genomic sequence to deduce the most likely positions of the
exon/intron boundaries for the canine homologue of
RPGRIP1. At the onset of the work the canine whole genome
sequence had yet to be assembled so BLASTn analysis was
carried out with the sequence of each exon from human
RPGRIP1 against canine WGS sequences in public databases.
Canine sequences with significant homology to each of the 24
human RPGRIP1 exons were assembled into contigs and the
most likely position of each exon/intron boundary was
identified. In most cases nucleotide (BLASTn) and protein
(tBLASTx) alignments between the canine RPGRIP1 genomic
sequence and the cDNA sequences of other species and the
presence of clear splicing signals led to clear predictions.
However, in some cases a clear alignment could not be found,
and predictions were based on maximizing protein alignments
and by additional use of the EMBOSS (http://www.emboss.
sourceforge.net/) programs syco, which is a frame-specificFig. 1. Pedigree informative for cord1, with haplotype data. Square symbols indicate
affected, those with black and white symbols are carriers, and those with unfilled sym
are indicated with a, b, and c. The order of loci is according to data from the current
Canis_familiaris/, and is consistent with data from the pedigree. Obligate non-Mende
indicated by question marks (?). The markers in red are those within the cord1 critic
unaffected chromosome is blue. The haplotypes have been drawn disregarding markegene finder that tries to recognize protein coding sequences by
virtue of the similarity of their codon usage to a codon
frequency table, and tcode, which uses the Fickett TEST-
CODE statistic to identify protein-coding DNA. By the end of
the study the canine whole genome sequence had been
assembled and annotated by the Ensembl automatic analysis
pipeline using a GeneWise model from a dog/vertebrate protein
[30,31], and canine RPGRIP1 exons had been predicted (http://
www.ensembl.org/Canis_familiaris/exonview?transcript=
ENSCAFT00000008883&db=core). Whereas the positions of
most intron/exon boundaries predicted in our study are identical
to those predicted by Ensembl, the boundaries of some exons
do differ. However, the supporting evidence for Ensembl's exon
predictions is provided solely by the sequence of bovine cDNA
[32]. In contrast, our exon/intron predictions were based on the
cDNA sequences of multiple species. Oligonucleotide primers
were designed to DNA within the introns of canine RPGRIP1
such that each exon and at least 100 nucleotides of each
flanking intron could be amplified by PCR. For exons for which
our exon/intron boundary predictions differed from those
predicted by Ensembl a sufficient length of DNA to cover
both boundary predictions was sequenced. Individual exons
were amplified and sequenced in a clear, a carrier, and an
affected dog and the sequences compared.
Identification of a mutation
An 44-bp insertion was identified in exon 2 in the affected
dog, comprising a poly(A) stretch flanked by a perfect 15-bp
duplication: g.8228_8229insA29GGAAGCAACAGGATG.
Determining the precise number of A nucleotides in the poly
(A) stretch was difficult, due to slippage occurring during the
initial PCR amplification. To overcome this, exon 2 was cloned
and sequenced from an affected dog, thus avoiding amplifica-
tion. The insertion was confirmed to comprise 29 A nucleotides
flanked by a perfect 15-bp duplication (A29GGAAGCA-
ACAGGATG). The reading frame of exon 2/exon 3 is changed
and a premature stop codon is introduced (Fig. 2). Exon 2 of all
the dogs within the pedigree was sequenced; all 15 affected
dogs were homozygous for the mutation and all 14 known
carriers were heterozygous.
In addition to the MLHDs from the inbred pedigree we
genotyped 38 MLHDs that were owned as pets in the United
Kingdom, the United States, or Australia and sampled with the
consent of their individual owners. These dogs were selected
from a large number of MLHDs recruited for the study by
advertising in the dog press and/or by personal communication
with MLHD owners because all 38 dogs had been examined by
veterinary ophthalmologists recognized under the British
Veterinary Association/Kennel Club/International Sheep Dogmale animals, circles indicate females; animals indicated with filled symbols are
bols are unaffected or unknown. Animals that are duplicated within the pedigree
full Ensembl gene build for C. familiaris, CanFam 1.0, http://www.ensembl.org/
lian alleles are indicated with exclamation markers (!!). Unknown genotypes are
al region. Disease chromosomes are indicated in green, red, and orange and the
r FH2017, which is based on a tetranucleotide repeat and is highly mutable [51].
Fig. 2. The RPGRIP1 exon 2 mutation. The DNA sequence and corresponding amino acids are indicated for clear and affected dogs. The intronic DNA has been
omitted. Nucleotides flanking the exon 2/exon 3 boundary are boxed, as are the amino acids that overlap the splice site. The 15-bp target site duplication is underlined.
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appropriate documentation to confirm the presence or absence
of clinical signs consistent with a cord1 diagnosis. Ten dogs
(26.32%) had been diagnosed as clinically normal and were
homozygous for wild-type RPGRIP1. Fourteen dogs (36.84%)
were also clinically normal and were heterozygous for the
mutation/wild-type RPGRIP1. Twelve dogs (31.58%) had been
diagnosed with clinical signs consistent with cord1 by a
veterinary ophthalmologist(s) and were homozygous for the
mutation. The remaining 2 dogs (5.3%) were homozygous for
themutation but had been diagnosed as clinically normal. The 38
dogs screened for the mutation had been recruited specifically to
study PRA in theMLHD, so did not represent a random subset of
the MLHD population. However, the high proportion of
heterozygotes that we identified indicates that the mutation is
very prevalent in the international MLHD population.
Discussion
Leber congenital amaurosis is the term for a group of retinal
dystrophies that represent the most common and severe form of
congenital visual impairment in infants and children. First
described by Theodore Leber [33] in 1869, LCA (MIM 204000)
is usually diagnosed at birth or during the first months of life in
infants with total blindness or greatly impaired vision, normal
fundus, and absent or extremely pathological electroretinogram
(ERG) [34]. LCA has an estimated prevalence of 1:50,000–
100,000 worldwide [35] and there is currently no treatment for
the condition.
LCA is genetically and clinically heterogeneous. To date, 10
LCA genes have been identified or mapped. For information
about LCA genes identified or mapped to date see the following
sources and references therein: [35,36] and http://www.sph.uth.
tmc.edu/RetNet/home.htm. Different LCA phenotypes have
been shown to correlate with mutations in different LCA genes.
Perrault and colleagues demonstrated that mutations in
GUCY2D cause severe congenital stationary cone–rod dystro-
phy, while RPE65 gene mutations confer a less severe but
progressive rod–cone dystrophy [37]. LCA patients can also be
distinguished according to whether their rods or cones de-
generate first, which is dependent on which LCA gene harbors a
mutation. Mutations in RPE65, TULP1, CRB1, and CRX confer
rod–cone dystrophies, whereas mutations in GUCY2D, AIPL1,
and RPGRIP1 cause cone–rod dystrophies [36]. The dramatic
heterogeneity observed between the different forms of LCA,
and the fact that there is currently no treatment for this blinding
condition, reaffirms the value of studying large animal models
of the condition to gain insight into the mechanisms behind the
phenotypic variation and to explore the development of
potential therapies.A severe inherited retinal degeneration has previously been
described in miniature longhaired dachshunds [21]. The earliest
ophthalmoscopic signs, which include changes in the granular
appearance of the tapetal fundus followed by generalized tapetal
hyperreflectivity and retinal vascular attenuation, are detectable
at approximately 6 months of age. The electroretinogram of
affected dogs is typically normal in waveform and latency at
10 weeks of age but markedly reduced in amplitude or even
virtually extinguished by 9 months. Significant histological
changes are visible at 10.5 weeks of age, including thinning of
the outer nuclear layer, irregularity and attenuation of the rod
photoreceptor outer segments, and early disorganization of the
rod outer segment disc lamellae, and by 25 weeks the
photoreceptors are grossly degenerate. Segregation patterns in
litters from matings involving affected individuals indicate a
simple autosomal recessive mode of inheritance [21].
Recently Turney and colleagues undertook extensive
analyses to characterize further this canine model of retinal
degeneration in the MLHD [22]. Extensive electrophysiological
recordings were made and compared with morphological lectin
and immunohistochemical changes identified within the retina.
The recordings indicated that at 6 weeks of age, the 30-Hz
flicker cone-specific ERG was reduced in amplitude in affected
animals, demonstrating loss of cone function, whereas rod-
specific ERGs were effectively normal at this stage. By
40 weeks of age the disease had progressed such that no
electrophysiological indication of residual photoreceptor func-
tion remained. With cone photoreceptors being more severely
affected in the first instance, followed by progressive rod
involvement, Turney et al. suggest that the retinal degeneration
in these animals is a cone–rod dystrophy and not, as previously
thought [21], a primary rod degeneration with secondary cone
loss [22]. We therefore term this retinal degeneration in MLHDs
cord1.
We mapped the retinal degeneration described above to a
14.15-Mb region of CFA15 that is syntenic with the region on
HSA14 that contains the RPGRIP1 gene, mutations in which
are well documented to cause LCA in human. Sequence
analysis of canine RPGRIP1 revealed an insertion in exon 2 of
affected dogs that alters the reading frame of the gene and
introduces a premature stop codon 80 nucleotides downstream.
The insertion comprises a poly(A) tract and 15 duplicated
nucleotides present in the wild-type allele at the insertion site
(i.e., a target-site duplication) (A29GGAAGCAACAGGATG;
Fig. 2), both features shared by many SINEs (short interspersed
repetitive DNA elements) that comprise a significant proportion
of eukaryotic genomes, including that of the dog [38–41].
Insertion of SINEs into coding sequence has been shown
previously to be a cause of inherited disease in dogs; Pele and
colleagues recently demonstrated that insertion of a SINE into
Table 2
Primers used to generate probes for screening canine BAC library and
genotyping microsatellites
Primer name Sequence Function Product
length
(bp)
AHTH257AF CTCTTCCCCACCTCCTTGA Generation
of PCR
product to
screen BAC
library
103
AHTH257AR GGGAGGCTGGAGGGATGT
06C11_OG_F GGGAAAACCTGATAAAAAGAAC Generation
of overgo
probe to
screen BAC
library
36
06C11_OG_R AAGATGCCTTTGAAGTTCTTTT
AHT43n7_F CTGCCTGAGGCTCACAGTTC Genotyping
microsatellite
AHT43n7
133/
141AHT43n7_R CCCGCAACCCTCTGTCTAC
61G2_E2_F CCTGGCTTGGAGAGACAACC Genotyping
microsatellite
61G2_E2
180/
18461G2_E2_R TTCCAGCCTTTCTTCAGAGG
61G2_E7_F
61G2_E7_R
CTTTGCATGGTGACTGAAGC
ATTCTGAACCGCCTCCTACC
Genotyping
microsatellite
61G2_E7
223/
233
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associated with the autosomal recessive centronuclear myopa-
thy in dogs [42].
All 15 affected dogs within the extended pedigree segregat-
ing cord1were homozygous for the mutation and all 14 obligate
carriers were heterozygous. The complete segregation of the
mutation with the cord1 phenotype indicates this mutation is
causal for cord1 in MLHDs.
We genotyped 38 outbred MLHDs, which had also been
clinically examined by veterinary ophthalmologists, for the
presence or absence of the RPGRIP1mutation. Thirty-six of the
38 dogs (94.74%) gave results consistent with an association
between the mutation and cord1. The average age of diagnosis
for the 12 affected dogs in this outbred group was 4.82 years,
suggesting the age of onset of ophthalmoscopic signs may be
later, on average, in outbred MLHDs than in the inbred pedigree
in which the earliest ophthalmoscopic signs appear at
approximately 6 months of age [21]. Two dogs were
homozygous for the mutation but had been diagnosed as
clinically normal. One of these dogs had been examined only
when it was 2 years of age, and no clinical updates were
available so it is unknown whether the dog ever developed
clinical signs. The remaining dog was reported to be clinically
unaffected at age 10.34 years of age. The observed variation in
age of onset of clinical signs for this condition is intriguing and
could suggest the presence of a modifier gene that controls the
penetrance or expressivity of the RPGRIP1 mutation, although
additional genetic and sequence analyses would be necessary to
confirm this hypothesis. Evidence of a modifier gene control-
ling the severity of LCA symptoms was provided by Silva and
colleagues [43], who identified a heterozygous GUCY2D
mutation in a human patient that also harbored a homozygous
mutation in RPE65. The patient's younger sibling carried the
RPE65 mutation only and suffered less severe symptoms. The
authors suggest the additional mutation further disrupts the
already compromised photoreceptor function, resulting in more
severe retinal dysfunction in the sibling with both mutations.
In addition to its involvement in LCA, mutations in
RPGRIP1 have been shown to be associated with CRDs in
human. Hameed et al. presented evidence for the involvement
of RPGRIP1 gene mutations as a cause of CRD in four Pakistani
families [44] and an independent comprehensive mutational
analysis of known LCA genes indicated that in human patients
with RPGRIP1 mutations the disease takes the form of
congenital or very early cone–rod dystrophy with dramatic
and invariable cone dysfunction [36]. The fact that the retinal
degeneration in MLHDs is apparently a cone–rod dystrophy
strengthens its role as an authentic model for LCA and similar
cone–rod dystrophies in human.
RPGRIP1 was identified through its interaction with RPGR
[32,45]. Both proteins localize in the photoreceptor connecting
cilium, a thin bridge lining the cell body and the light-sensing
outer segment of the photoreceptor [46]. RPGRIP1 is required
for the normal localization and proposed function of RPGR in
regulating protein trafficking across the connecting cilia [47]
and is required for disk morphogenesis [46]. Gene therapy
represents an attractive approach for treating LCA because theeye is easily accessible, allowing local application of
therapeutic vectors. The best known example of therapy for
retinal diseases in general, and for LCA in particular, involves
the Briard dog model [16], in which the defective RPE65 gene
was replaced by a normal copy via transfer by an adeno-
associated viral vector [1]. Subsequent analysis of treated eyes
by ERG revealed substantial restoration of both rod and cone
function confirmed by behavioral tests [1,48].
This study describes the identification and characterization
of an alternative canine model of LCA, which provides an
additional opportunity for the development and refinement of
therapeutic strategies involving gene replacement as treatment
for the more severe forms of LCA.
Materials and methods
Oligonucleotide primers
Primers used to probe the canine BAC library are shown in Table 2. The
sequences of primers used to genotype microsatellites were taken from
published sources, unless otherwise stated, and are indicated in Table 2.
Microsatellite analysis
Microsatellites were amplified by PCR using either standard (1 min at 95°C,
1 min at annealing temperature, 1 min at 72°C for 30 cycles), “touch-down” [49],
or published ([26] and references therein) conditions on a PTC-225 thermal
cycler (MJ Research). PCR fragments were analyzed on an ABI 3100 automated
genetic analyzer (Applied Biosystems). Results were analyzed with Genescan
2.1, Genotyper 1.1.1, and GeneMapper software (Applied Biosystems) and
entered into Cyrillic 2.1.3 (Family Genetix Ltd.) for further manipulation and
haplotype analysis.
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High-density gridded filter sets of a canine genomic BAC library with an
eightfold redundancy [24] were provided by the HGMP Resource Centre
(Hinxton, Cambridge, UK). Probes were labeled by one of two methods. If the
probe was a PCR product, it was labeled during PCR, by replacing 147 pmol of
dATP with 1.11 MBq (∼110 TBq/mmol) of [α-32P]dATP in the reaction mix,
and purified using Chroma spin +TE-10 columns (Clontech). Alternatively,
overgo probes were labeled by the method described by Han [50]. Hybridization
was at 65°C for 16 h. Filters were washed at 42 (CPH4) or 65°C (others) in 2×
SSC/0.1% SDS, enclosed in Saran Wrap, and exposed to BioMax FS film
(Kodak) for 1 to 3 days at room temperature. The identity of positive BAC
clones was routinely confirmed by amplification of a PCR fragment of the
correct size and sequencing.
Subcloning of BAC DNA into pUC18 vector
Ultrapure, high-molecular-weight BAC DNA was prepared using a PSI ψ
Clone Big BAC DNA isolation kit (Princeton Separations) according to the
manufacturer's instructions. High-molecular-weight BAC DNA (2.5 μg) was
sonicated, size-fractionated, and cloned into pUC18 using methods developed at
the Sanger Institute (http://www.sanger.ac.uk/Teams/Team53/).
Isolation of plasmid DNA
The REAL Prep 96 Plasmid Kit (Qiagen) was used to isolate plasmid DNA
from white recombinant clones for sequencing following the manufacturer's
protocol with the inclusion of the optional 5-min boiling step before lysate
filtration. Plasmid DNAwas resuspended in 50 μl of 10 mM Tris–HCl, pH 8.5,
and stored at −20°C.
Cloning of genomic fragment containing cord1 mutation
Genomic DNAwas digested using EcoRI and BamHI (Roche) according to
the manufacturer's recommended conditions. Ligations were transformed into
ElectroMAX DH12S competent cells (Invitrogen) according to the manufac-
turer's recommended conditions, and pools of colonies were screened by PCR
for the desired clone. When a positive pool was identified, the colonies were
replated at a lower dilution and the process was repeated. At the third pass
individual colonies were tested by PCR. DNAwas made from positive colonies
as described above, and colonies were sequenced as described below.
Plasmid DNA sequencing and analysis
Plasmid DNAwas sequenced using 5 μl of DNA (200–500 ng), 1.6 pmol of
−21 M13 forward/−29 M13 reverse primers, 2 μl of Big Dye Terminator mix,
2 μl of dilution buffer (400 mM Tris, pH 9.0, 10 mM MgCl2), and deionized
water in a volume of 10 μl. Reactions were performed in 96-well PCR plates
(ABgene) for cycle sequencing under the following conditions: 96°C for 3 min;
then 25 cycles of 96°C for 30 s, 50°C for 15 s, 60°C for 4 min; followed by 4°C
for 5 min. Sequencing reactions were precipitated by addition of 1 μl of 3 M
NaOAc, pH 4.6, and 25 μl of ice-cold 100% EtOH. Samples were mixed and
incubated at room temperature for 15 min before being pelleted at 4000 rpm for
30 min in an Eppendorf 5804 benchtop centrifuge. Plates were inverted and
centrifuged for 2 min at 250 rpm. Pellets were washed by adding 125 μl of 70%
EtOH and repelleted at 4000 rpm for 10 min. Plates were incubated at 37°C to
dry for 15 min and 10 μl of Hi-Di formamide was added. Plates were heated at
95°C for 1 min and transferred to ice for 2 min before being placed onto a 3100
DNA sequencer for electrophoresis. Sequences were viewed using Sequence
Analysis v3.7 (Applied Biosystems).
Animals
The animals were bred and studied under the regulations of the United
Kingdom Animals (Scientific Procedures) Act 1986 and all animal procedures
adhered to the Association for Research in Vision and Ophthalmology resolution
for the care and use of animals in vision research.Acknowledgments
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